Evaluation of gadolinium-based contrast agents in pregnant CD-1 mice and subsequent in utero exposure of the developing offspring, including behavioral evaluations.

Autor: Lewis EM; Charles River Laboratories, Inc., Safety Assessment, Horsham, Pennsylvania, USA., Bussi S; Bracco Imaging SpA, Milan, Italy., Fretellier N; Guerbet, Roissy, France., Clemens G; Bayer AG, Pharmaceuticals Research & Development, Berlin, Germany., Jones P; GE Healthcare, Pharmaceutical Diagnostics, Chalfont St. Giles, United Kingdom., Tedoldi F; Bracco Imaging SpA, Milan, Italy., Bourrinet P; Guerbet, Roissy, France., Czupalla O; Bayer AG, Pharmaceuticals Research & Development, Berlin, Germany., Hirani E; GE Healthcare, Pharmaceutical Diagnostics, Chalfont St. Giles, United Kingdom., Hoberman AM; Charles River Laboratories, Inc., Safety Assessment, Horsham, Pennsylvania, USA.

Publikováno v: Birth defects research [Birth Defects Res] 2024 Jan; Vol. 116 (1), pp. e2291. Date of Electronic Publication: 2023 Dec 29.

Evaluation of [methyl- 3H]L655,708 and [ethyl- 3H]RY80 as putative PET ligands for central GABA A receptors containing α5 subunit

Autor: Opacka-Juffry, J. ^*, Hirani, E., Dawson, G.R., Luthra, S.K., Hume, S.P.

Publikováno v: In Nuclear Medicine and Biology 1999 26(7):743-748

Pindolol occupancy of 5-HT(1A) receptors measured in vivo using small animal positron emission tomography with carbon-11 labeled WAY 100635

Autor: Hirani, E, Opacka-Juffry, J, Gunn, R, Khan, I, Sharp, T, Hume, S

Positron emission tomography (PET), following an intravenous injection of [carbonyl-(11)C]WAY 100635, was used to image central 5-HT(1A) receptors in rat following pretreatment with graded doses of (-)-pindolol (0.001-3 mg/kg, i.v.). The use of PET h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::743af9d05aa5c098f06e76cdd1fb47b2
https://ora.ox.ac.uk/objects/uuid:0bedc28c-7317-4fa7-a1e5-060ff3956263

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Amyloid-Targeting PET Tracer [ ¹⁸ F]Flutemetamol Accumulates in Atherosclerotic Plaques.

Autor: Hellberg S; Turku PET Centre, University of Turku, FI-20520 Turku, Finland. sanna.hellberg@utu.fi., Silvola JMU; Turku PET Centre, University of Turku, FI-20520 Turku, Finland. johanna.silvola@gmail.com., Liljenbäck H; Turku PET Centre, University of Turku, FI-20520 Turku, Finland. halilj@utu.fi.; Turku Center for Disease Modeling, University of Turku, FI-20520 Turku, Finland. halilj@utu.fi., Kiugel M; Turku PET Centre, University of Turku, FI-20520 Turku, Finland. max.kiugel@utu.fi., Eskola O; Turku PET Centre, University of Turku, FI-20520 Turku, Finland. olli.eskola@utu.fi., Hakovirta H; Department of Vascular Surgery, Turku University Hospital, FI-20520 Turku, Finland. harri.hakovirta@tyks.fi., Hörkkö S; Medical Research Center and Nordlab Oulu, University Hospital and Research Unit of Biomedicine, Faculty of Medicine, University of Oulu, FI-90014 Oulu, Finland. sohvi.horkko@oulu.fi., Morisson-Iveson V; GE Healthcare Ltd., Chalfont St Giles HP8 4SP, UK. Veronique.MorissonIveson@ge.com., Hirani E; GE Healthcare Ltd., Chalfont St Giles HP8 4SP, UK. Ella.Hirani@ge.com., Saukko P; Department of Pathology and Forensic Medicine, University of Turku, FI-20520 Turku, Finland. psaukko@utu.fi., Ylä-Herttuala S; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, FI-70210 Kuopio, Finland. seppo.ylaherttuala@uef.fi., Knuuti J; Turku PET Centre, University of Turku, FI-20520 Turku, Finland. juhani.knuuti@utu.fi., Saraste A; Turku PET Centre, University of Turku, FI-20520 Turku, Finland. antti.saraste@utu.fi.; Turku PET Centre, Turku University Hospital, FI-20520 Turku, Finland. antti.saraste@utu.fi.; Heart Center, Turku University Hospital, FI-20520 Turku, Finland. antti.saraste@utu.fi.; Department of Clinical Medicine, University of Turku, FI-20520 Turku, Finland. antti.saraste@utu.fi., Roivainen A; Turku PET Centre, University of Turku, FI-20520 Turku, Finland. anne.roivainen@utu.fi.; Turku Center for Disease Modeling, University of Turku, FI-20520 Turku, Finland. anne.roivainen@utu.fi.

Publikováno v: Molecules (Basel, Switzerland) [Molecules] 2019 Mar 19; Vol. 24 (6). Date of Electronic Publication: 2019 Mar 19.